I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Whole exome sequencing and comprehensive disease-specific massively parallel gene sequencing are increasingly becoming important in the diagnosis and understanding of neurobiology. Homozygous *SYNJ1* mutation-related phenotypes are insufficiently characterized and have been reported to include movement disorder and early infantile epileptic encephalopathy-53 (EIEE53) \[OMIM \#617389\]. Previously, EIEE53 has been described in four unrelated families. We report a patient with *SYNJ1* homozygous novel pathogenic mutation with early-onset epileptic encephalopathy, hypotonia progressing to spastic quadriparesis, cortical visual impairment, opisthotonus, and dystonia and summarize the electroclinical syndrome of this rare epileptic encephalopathy.

C[ASE]{.smallcaps} D[ESCRIPTION]{.smallcaps} {#sec1-2}
============================================

The patient was born at 39 weeks of gestation to a healthy 22-year-old G2 P1 woman after an unremarkable pregnancy and delivery. Birth weight was 3160g and head circumference was 35.5 cm (35th percentile). Parents were first cousins of Saudi Arabian descent with no family history of neurodegenerative disease. The girl infant presented at 2 days of age with episodes of eye twitching, body stiffening, and bicycling movements of legs. No striking facial dysmorphism was observed, but she had profound hypotonia. Prolonged video electroencephalography captured multifocal seizures \[[Figure 1](#F1){ref-type="fig"}\]. Seizures were initially controlled with phenobarbital, but it was switched to levetiracetam because of excessive sedation. She had also opisthotonic posturing that responded to baclofen. She stayed in the intensive care unit for 2 months because of intermittent recurrence of seizures and poor feeding. She was started on oxcarbazepine, topiramate, and clonazepam during that time. She received a gastrostomy tube before discharge. Her brain magnetic resonance imaging (MRI) was normal. Chromosomal microarray showed multiple long continuous stretches of homozygosity. Sequencing and deletion/duplication analysis of 22 epilepsy genes did not reveal any pathogenic variant. Whole exome sequence analysis showed a homozygous pathogenic variant (variant p.Q287PfsX27; coding DNA c.858_862delACAAA) in the *SYNJ1* gene. At the age of 8 months, she started to have episodes of epileptic spasms and interictal electroencephalogram (EEG) showed modified hypsarrhythmia \[[Figure 2](#F2){ref-type="fig"}\]. Her spasms remained intractable to adrenocorticotropic hormone, vigabatrin, cannabidiol oil, ketogenic diet, and vagus nerve stimulation. She also developed myoclonic seizures. During her last follow-up at the age of 28 months, she was noted to have a profound developmental delay with the developmental milestone of 2-month level. She had a severe cortical visual impairment, and her hypotonic muscle tone was evolved to severe spastic quadriparesis. Head circumference was 46.5 cm (16th percentile). She had brisk deep tendon reflexes, but plantars were mute. She had also persistent dystonic posturing of upper extremities (partially responded to clonazepam) and intermittent episodes of spasms and myoclonic seizures.

![Ictal electroencephalography during the neonatal period: focal seizure involving bilateral central chains (top) and focal seizure involving right more than the left temporal chain (bottom)](JPN-15-29-g001){#F1}

![Ictal electroencephalography during the neonatal period: focal seizure involving bilateral central chains (top) and focal seizure involving right more than the left temporal chain (bottom)](JPN-15-29-g002){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-3}
========================

The c.858_862delACAAA pathogenic variant in the *SYNJ1* gene has not been reported previously. This variant causes a frameshift starting with codon glutamine 287, changes this amino acid to a proline residue, and creates a premature stop codon at position 27 of the new reading frame, denoted p.Gln287ProfsX27. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated messenger ribonucleic acid (mRNA) decay. This variant was not observed in the NHLBI Exome Sequencing Project, which indicates that it is not a common benign variant.

*SYNJ1* gene encodes a polyphosphoinositide phosphatase that plays an important role in clathrin-coated pit-mediated endocytosis.\[[@ref1]\] Biallelic genetic disruption of *SYNJ1* results in impaired synaptic vesicle recycling dynamics and accumulation of clathrin-coated vesicles in knockout mice and zebra fish models.\[[@ref2]\]

Krebs *et al.*\[[@ref3]\] identified a homozygous missense mutation of the Sac1 domain of *SYNJ1* in a consanguineous Iranian family with early‐onset progressive parkinsonism with generalized seizures. This mutation selectively abolishes the phosphatase function of the domain. Affected patients showed progressive movement disorder in their second or third decade of life with or without cognitive deterioration, dystonia, and cerebral cortical atrophy. Quadri *et al.*\[[@ref4]\] reported similar early-onset parkinsonism in an Italian family. Some of these patients had a developmental delay or rare seizures prior to the onset of progressive movement disorder. However, Dyment *et al.*\[[@ref5]\] reported a novel phenotype with intractable early-onset epilepsy and profound intellectual impairment from a homozygous nonsense variant (p.Arg136\*) resulting in loss of protein formation. Furthermore, children from three unrelated family with early-onset refractory seizure were described by Hardies *et al.*\[[@ref6]\] because of the homozygous or compound heterozygote nonsense variants causing a critical reduction of the dual phosphate activity and loss of mRNA transcript rather than a selective decrease of Sac1 function seen in phenotypes associated with early-onset parkinsonism. Al Zaabi *et al.*\[[@ref7]\] later reported two related children with a homozygous mutation in *SYNJ1* (c.709C\>T, p.Gln237\*) from a consanguineous Emirati family of Omani origin, who presented with neonatal-onset pharmacoresistant seizures and a neurodegenerative disease course. Early hypotonia with later development of spastic quadriparesis, dystonia, and vision impairment are typical findings of this neurodegenerative condition as noted in our patient. Most affected children died in childhood, and one child was noted to have tau-positive neurofibrillary tangles in the substantia nigra.

Seizure onset was described from day 1 of life to as late as 6 months of age. Tonic-clonic, myoclonic, tonic, and epileptic spasms were described \[[Table 1](#T1){ref-type="table"}\]. All patients are uniformly treatment resistant and status epilepticus had been reported. Most commonly reported seizure is the myoclonic seizure. Interestingly, two patients had high lactate, liver disease, and combined deficiency of complex III and IV activity in liver and fibroblasts. Mitochondrial DNA screening was negative. Our patient also had an extensive evaluation for mitochondrial disease; however, metabolic and genetic studies were unremarkable for mitochondrial disease. Dystonia has been reported in one family. Our case is the second reported case and had improvement with the use of clonazepam, which indicates a possible use for this indication in these patients. No patients with homozygous nonsense mutation developed a parkinsonian feature, which is a key finding in association with a homozygous missense mutation. EEG showed the following variable findings: slow background, multifocal epileptiform discharges, hypsarrhythmia, and ictal findings associated with focal and myoclonic seizures. Our patient had normal brain MRI findings including spectroscopy, which is consistent with previously reported patients except inconsistent finding of decreased *N*-acetyl acetate to choline ratio, large creatine peak, and mild cerebral atrophy. Inconsistently creatine kinase elevation and decreased complex I activity and mild variation in fiber sizes were noted.

###### 

Phenotypic spectrum of *SYNJ1* epileptic encephalopathy (early infantile epileptic encephalopathy-53)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Our reported patient
  ----------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------
                                **Boy**                                                                                                                                                                     **Girl**                                                                                                                                                      **Boy**                                                                                                                                                       **Girl**                                                                                    **Girl**                                                                                    **Boy**                                                                                                                                                              **Boy**                                                                                                                                        **Girl**                                                                               **Boy**                                                                                    **Girl**
  **Intellectual impairment**   **Profound delay**                                                                                                                                                          **Profound delay**                                                                                                                                            **Profound delay**                                                                                                                                            **Profound delay**                                                                          **Profound delay**                                                                          **Profound delay**                                                                                                                                                   **Profound delay**                                                                                                                             **Severe delay**                                                                       **Profound delay**                                                                         **Profound delay**
  Seizure                       Clusters of tonic seizures, tonic- clonic seizures from day 9 of life                                                                                                       Flexion spasm at 10 months (may have started at 2.5 months) Developed myoclonic and tonic seizures                                                            Epileptic spasms at 6 months Developed myoclonic and tonic seizures                                                                                           Clonic seizure during day 1 of life and then developed myoclonic and tonic-clonic seizure   Clonic seizure during day 1 of life and then developed myoclonic and tonic-clonic seizure   Eye blinking and shoulder movement from Day 12 of life and then evolved into myoclonic and tonic-clonic type                                                         Eye deviation from Day 1 of life and then refractory GTC and myoclonic seizures                                                                Lip smacking and tonic seizures from D2 of life                                        Epileptic spasms, tonic clonic seizures, and myoclonus                                     Multifocal seizures from 2 days of age. Later developed epileptic spasms and myoclonic seizures
  EEG                           Modified hypsarrhythmia                                                                                                                                                     modified hypsarrhythmia or multifocal epileptic activity on a slow background                                                                                 modified hypsarrhythmia or multifocal epileptic activity on a slow background                                                                                 modified hypsarrhythmia or focal spikes on a slow background                                modified hypsarrhythmia or focal spikes on a slow background                                Multifocal epileptiform activity in a slow background                                                                                                                Multifocal epileptiform activity in a slow background                                                                                          Hypsarrhythmia                                                                         Hypsarrhythmia                                                                             modified hypsarrhythmia or multifocal epileptic activity on a slow background
  Brain MRI                     Mild cerebral atrophy at 5 years of age                                                                                                                                     normal                                                                                                                                                        normal                                                                                                                                                        normal                                                                                      normal                                                                                      normal                                                                                                                                                               thin corpus callosum and limited gliosis and atrophy of the periventricular white matter                                                       normal                                                                                 Mild dilatation of ventricles and subarachnoid spaces                                      normal
  Dystonia                      Not available                                                                                                                                                               no                                                                                                                                                            no                                                                                                                                                            no                                                                                          no                                                                                          yes                                                                                                                                                                  Yes                                                                                                                                            no                                                                                     no                                                                                         Yes
  Parkinsonism                  Not available                                                                                                                                                               no                                                                                                                                                            no                                                                                                                                                            no                                                                                          no                                                                                          no                                                                                                                                                                   no                                                                                                                                             no                                                                                     no                                                                                         no
  Other clinical features       Progressive neurodegenerative course, feeding intolerance, and G tube dependence, hypotonia progressed to multiple contractures, cortical blindness, Death at age 6 years   Progressive neurodegenerative course, feeding intolerance, and G tube dependence, hypotonia progressed to spastic quadriparesis, cortical visual impairment   Progressive neurodegenerative course, feeding intolerance, and G tube dependence, hypotonia progressed to spastic quadriparesis, cortical visual impairment   Progressive spastic quadriplegia and feeding problem                                        Progressive spastic quadriplegia and feeding problem                                        Progressive neurodegenerative course, feeding intolerance, and G tube dependence, hypotonia progressed to hypetonia to opisthotonus, Death at the age of 2.5 years   Progressive neurodegenerative course with death at the age of 8 years, spastic quadriparesis, cotical visual impairment, feeding dysfunction   Both developed acquired microcephaly and axial hypotnia and girl child had scoliosis   Hypotonia progressed to spastic quadriparesis, feeding intolerance and G tube dependence   
  Other features                Decreased complex I activity and predominance of type 2 fibers in the muscle biopsy, tau- immunoreactive neurofibrillary degeneration in the substantia nigra                                                                                                                                                                                                                                                                                                                                           high lactate, combined deficiency in complex III and IV activity in liver and fibroblasts   Increased creatine kinase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

We described a girl with developmental and epileptic encephalopathy with a novel homozygous frameshift variant in the *SYNJ1* gene. This case highlights a strong genotype--phenotype correlation in this early-onset epileptic encephalopathy with a homozygous nonsense variant in the *SYNJ1*. However, phenotype, neuroimaging, and EEG features are not sufficient to diagnose *SYNJ1* encephalopathy and all genes (\>67 genes) responsible for early-onset epileptic encephalopathy should be included in the differential diagnosis.
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